Kingsley will join forces with Nvidia to host the Life Science Startup Venture Capital Contest, a global competition for startups applying artificial intelligence to therapeutic drug development and life sciences. The project integrates Kingsley's wet experimental verification and data generation capabilities, as well as Nvidia's accelerated computing platform and startup ecosystem. The event will be held during the J.P. Morgan Healthcare Conference in January 2027. It is planned to select up to six companies to participate in the live roadshow. The winning company will receive a wet test data credit provided by Kingsley and a Brev cloud service credit from Nvidia to support subsequent development and deployment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.